Le Lézard
Classified in: Health
Subjects: VET, DIS, MAT

Veterans Push For A Federal Study Of Hemp In Hopes Of Stemming Opioid Prescriptions At VA Facilities


WASHINGTON, April 20, 2018 /PRNewswire/ -- A group of United States Armed Forces Veterans descended on the U.S. House of Representatives in Washington, D.C. Tuesday, April 17 to meet with members of the Cannabis Caucus and the House Veterans' Affairs Committee. Their request is an urgent call for change in medical treatment options for Veterans: stop the dependency on opioids and compel the Veterans' Affairs Administration to study CBD derived from industrial hemp as a legal alternative to opioids, the go-to drug in masking a variety of medical conditions.

Veterans Christine Clayburg, Veronica Wayne and Warfighter Hemp founder Steve Danyluk prepare to meet with members of the Cannabis Caucus and House Committee on Veterans Affairs to discuss urging the VA to study CBD derived from industrial hemp as a treatment option for Veterans in light of the opioid crisis.

Steve Danyluk, who spearheaded the legislative meeting with Veterans, is retired from the Marine Corps Reserves. His last position was working wounded issues at Walter Reed and Bethesda. That is where he became very troubled by what he saw.

"I witnessed what I believe is a policy of overmedicating wounded service men and women with opiates and other toxic medications, which led me to establish Warfighter Hemp," said Steve Danyluk, LtCol, USMCR (RET.) and founder Warfighter Hemp. "CBD derived from Industrial Hemp provides much of the relief that these Veterans seek, at a fraction of the cost, without the psychoactive side effects, making it an ideal alternative to the various psychotropic and toxic medications in the VA's dispensary. We welcomed the opportunity to share our CBD stories with legislators."

Danyluk, along with three Veterans from Minnesota and Virginia, met with Congressman Jared Polis (D) Colorado, Congressman Earl Blumenauer (D) Oregon, and representatives from the offices of combat Veteran Congressman Moulton (D) Massachuetts, Congressman Don Young (R) Alaska, and Congressman Tim Walz (D) Minnesota. The group met individually with Congressman Brian Mast (R) Florida, himself a combat Veteran, along with an aide for Congressman Scott Peters (D) Ohio.

The group requested legislators sign a letter to Acting Secretary Robert Wilke, Department of Veterans Affairs, asking him to green light a study into CBD derived from Industrial Hemp.

This comes on the heels of a request by several members of the House Veterans' Affairs Committee requesting that the VA study medical marijuana. The request was rejected. However, on Wednesday, Congressman Lou Correa (D) California joined Ranking Member Walz and Chairman Phil Roe (R) Tennessee in introducing the bipartisan VA Medicinal Cannabis Research Act. The bill clarifies that the VA has the authority to conduct medical cannabis research and requires the Department to report to Congress on how it will use that authority.

The move is prompting positive response.  "After taking a sister soldier's advice, I was able to trade out the VA "zombie cocktail" for CBD oil.  Not long after that I began to feel an occasional sense of joy for the first time in over two years," said TSgt Christine Clayburg.  "Is it too much to ask that the VA at least test this plant that its own warriors are telling them is working?"

To advocate for the study of hemp, contact your Congressman or Congresswoman in the US House of Representative. To learn more, visit WarfighterHemp.com or follow on Facebook.

About Warfighter Hemp 
Warfighter Hemp is comprised of veterans and non-veterans who strive to provide an alternative to the medical reality that many veterans face. We develop CBD oil products derived from hemp, a federally legal and non-marijuana plant grown on USDA organic land at our fourth-generation family farm in Eaton, Colorado.  We give 50 percent of our profits to other charities that support veteran's independence.  

 

SOURCE Warfighter Hemp


These press releases may also interest you

at 18:42
George Weston Limited ("Weston" or the "Company") today announced that all of the nominee directors listed in its management proxy circular dated March 19, 2024, were elected as directors of the Company. The vote was conducted at the Company's...

at 18:41
Family Source Consultants, LLC, a leading provider of surrogacy, egg donation, and all third-party reproduction services, is excited to announce the grand opening of its new state-of-the-art office dedicated to enhancing the journeys of intended...

at 18:15
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024....

at 18:00
In recognition of Mother's Day on May 12th, Denny's Canada is delighted to announce that they have partnered with Women's Health Collective Canada (WHCC) to host a special fundraiser. From May 7th to 12th, in participating stores across Canada, $2...

at 17:41
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial...

at 17:09
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for...



News published on and distributed by: